Introduction to Infliximab A. Overview of Infliximab 1. Definition and Purpose:Infliximab is a monoclonal antibody used primarily in the treatment of autoimmune diseases. It targets tumor necrosis factor alpha (TNFα), a substance in the body that causes inflammation and is involved in autoimmune diseases. By neutralizing the activity of TNFα, infliximab helps reduce inflammation...

Introduction to Infliximab A. Overview of Infliximab 1. Definition and Purpose:Infliximab is a monoclonal antibody used primarily in the treatment of autoimmune diseases. It targets tumor necrosis factor alpha (TNFα), a substance in the body that causes inflammation and is involved in autoimmune diseases. By neutralizing the activity of TNFα, infliximab helps reduce inflammation...

Introduction Cervical cancer remains a significant public health issue worldwide, affecting millions of women. Despite advancements in detection and treatment, it continues to pose serious challenges, particularly in low- and middle-income countries. This article explores the global cervical cancer treatment market, which was valued at USD 7.24 billion in 2023 and is projected to grow at a...

Parasitic diseases, such as malaria, leishmaniasis, and schistosomiasis, pose significant health challenges globally, particularly in tropical and subtropical regions. These diseases are caused by various parasites, including protozoa, helminths, and ectoparasites, leading to a wide range of symptoms and, in severe cases, death. The global parasitic diseases therapeutics market, valued at USD...

Introduction The global BREO Ellipta drugs market is witnessing significant growth, driven by the expanding chronic obstructive pulmonary disease (COPD) drugs market. Experts predict that this market is likely to grow at a commendable rate of 4.5% during the forecast period of 2024-2032. The prevalence of respiratory diseases, particularly COPD, is expected to surge in the coming years, mainly...

The global orthopaedic soft tissue repair market is undergoing significant growth, driven by the prevalence of new technical advances to treat soft tissue injuries across the globe. In 2023, the market was valued at USD 6.4 billion, and it is expected to continue growing at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period of 2024-2032, with values likely to reach USD 11.1...

Introduction: The global spine surgery robots market has witnessed remarkable growth in recent years, with a value of USD 133.11 million in 2023. This surge is attributed to the rising prevalence of chronic back pain across the globe. Projections indicate a promising future, with an expected Compound Annual Growth Rate (CAGR) of 11.6% during the forecast period from 2024 to 2032, ultimately...